With cancer cases in India expected to double in 10 years, India’s largest cancer hospital is harnessing technology as an important diagnostic tool for the future
Called the Mammography Screening with Artificial Intelligence (MASAI) trial, the study said it was the first randomised controlled trial evaluating the effects of AI-supported screening.
In a study led by researchers at Harvard Medical School and the University of Copenhagen, an AI tool was successfully used to predict the risk of pancreatic cancer.